Palo Alto – April 4, 2016 – The Recorder recognized Cooley’s Venture Capital group as a Corporate Department of the Year at its 2016 Corporate Departments of the Year & GC Impact Awards – the second time the group has been honored. Cooley partner and M&A head Barbara Borden was also named a life sciences Trusted Advisor at the awards.
The publication notes that Cooley “led the way in China-focused fund formation, and got creative in the ‘social good’ space.
Cooley is counsel to more than 325 fund organizations worldwide, including more than 40 fund managers with their primary operations in China. In 2015, Cooley helped form more than 190 venture funds, raising $19 billion dollars. Thus far in 2016, Cooley has advised on 51 fund closings with an aggregate amount raised of $6 billion, including four $1+ billion funds. In Q1, Cooley advised on more than $3 billion of fundraising activity in China – a feat unmatched by other foreign law firms practicing fund formation in China.
In the “social good” space, Cooley advised DBL Partners on the formation of a $400 million fund formed to invest “double bottom line” venture capital into startups that combine a compelling economic rationale (first bottom line) with a positive social or environmental impact (second bottom line). The fund was significantly oversubscribed and is considered to be the largest social impact venture fund in existence.
Borden was recognized as one of only ten “trusted advisors who made pivotal contributions in transactions last year.” She specializes in mergers and acquisitions, cross border transactions, joint ventures and other complex transactions and public securities law. Most recently in the life sciences space, Borden advised Horizon Pharma on its acquisition of Crealta for $510 million; Auspex on its sale to Teva for $3.5 billion; Horizon Pharma on its acquisition of Hyperion for $1.1 billion; and Volcano on its sale to Royal Philips for $1.2 billion.
View the article here.
About Cooley LLP
Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law.
Cooley has 900 lawyers across 12 offices in the United States, China and Europe.